Botanical species · safety record

Salix purpurea

The EFSA Compendium of Botanicals holds 6 constituent measurements for Salix purpurea. This page reports what those source records contain and how to reach them. It carries no effect estimate, no dose and no recommendation.

Accepted name in source: Salix purpurea L.

6Constituent measurements
0Safety records
4Cited sources
1Licensed products (Canada)

Regulatory presence

Health Canada's Licensed Natural Health Products Database holds 1 licensed products naming Salix purpurea as a medicinal ingredient, matched on the exact Latin binomial. A licence records that a product met the regulator's requirements for sale in Canada. It is not evidence that the product works.

Source material stated

  • Bark

What the records describe

Constituents measured

  • Salicylates3
  • Eleutheroside b2
  • Benzene-1,2-diol1

Plant parts

  • Bark5
  • Leaves1

Preparations

  • Solvent extraction6

Recorded constituents

What analytical work has found in this species, at which plant part and preparation. A measured constituent is a fact about material, not about effect.

SubstancePlant partPreparationConcentrationAnalytical methodSource
Benzene-1,2-diolBarkSolvent extractionHPLC with standard detection methodsResolve DOI
SalicylatesLeavesSolvent extractionHigh Performance Liquid Chromatography (HPLC)/Liquid Chromatography (LC)Resolve DOI
SalicylatesBarkSolvent extractionHPLC with standard detection methodsResolve DOI
Eleutheroside bBarkSolvent extraction≤ 0.2 PercentHigh Performance Liquid Chromatography (HPLC)/Liquid Chromatography (LC)No resolvable identifier
Eleutheroside bBarkSolvent extraction≥ 0.03 PercentHigh Performance Liquid Chromatography (HPLC)/Liquid Chromatography (LC)No resolvable identifier
SalicylatesBarkSolvent extractionHigh Performance Liquid Chromatography (HPLC)/Liquid Chromatography (LC)No resolvable identifier

Cited sources

The literature the compendium cites for this species. Metatron Health has no relationship with these authors or journals and earns nothing from citing them.

  1. Poblocka-Olech, Loretta., Krauze-Baranowska, Miroslawa., Glod, Daniel., Kawiak, Anna., Lojkowska, Ewa. Chromatographic Analysis of Simple Phenols in Some Species from the Genus Salix. PHYTOCHEMICAL ANALYSIS, 2010, vol. 21, no. 5, p. 463-469. DOI
  2. Meier, B., Lehmann, D., Sticher, O., Bettschart, A. Identification and determination of eight phenolic glycosides in Salix purpurea and Salix daphnoides with modern HPLC. Pharmaceutica acta helvetiae, 1985, p. 269-275.
  3. Julkunen-Tiitto, R., Sorsa, S. Testing the effects of drying methods on willow flavonoids, tannins, and salicylates . Journal of chemical ecology, 2001, vol. 27, no. 4, p. 779-789. DOI
  4. Poblocka-Olech, Loretta., van Nederkassel, Anne-Marie., Heyden, Yvan Vander., Krauze-Baranowska, Miroslawa., Glod, Daniel., Baczek, Tomasz. Chromatographic analysis of salicylic compounds in different species of the genus Salix. JOURNAL OF SEPARATION SCIENCE, 2007, vol. 30, no. 17, p. 2958-2966. DOI

Boundary

A constituent measurement is a fact about material at a stated preparation, not a statement about what that material does in a person. An adverse-effect or genotoxicity record is an observation reported in a source, most often in an animal or laboratory model. Neither is a Metatron Health conclusion about causality, human risk or benefit, and the absence of a record is not proof that a preparation is safe. Nothing here is diagnosis, prescribing or individual medical care.

Continue